Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

• Status: Completed
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will evaluate the safety and efficacy of LATISSE® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost

Criteria

Inclusion Criteria:

• Eyelash prominence assessment of minimal or moderate

• Of Korean ethnicity

Exclusion Criteria:

• Any eye disease or abnormality

• Any ocular surgery or use of any eyelash extension or eyelash growth products within 3 months

• Any permanent eyeliner within 5 years

• Eyelash implants of any kind

• Eyelash tint or dye application within 2 months

• Use of any treatment that may affect hair growth within 6 months